Alimera Sciences, Inc.
ALIM · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Revenue | $80,754 | $54,129 | $59,029 | $50,820 |
| % Growth | 49.2% | -8.3% | 16.2% | – |
| Cost of Goods Sold | $19,584 | $7,977 | $7,030 | $6,941 |
| Gross Profit | $61,170 | $46,152 | $51,999 | $43,879 |
| % Margin | 75.7% | 85.3% | 88.1% | 86.3% |
| R&D Expenses | $16,626 | $16,228 | $13,778 | $9,668 |
| G&A Expenses | $18,530 | $12,871 | $12,774 | $11,652 |
| SG&A Expenses | $46,015 | $38,858 | $35,843 | $32,036 |
| Sales & Mktg Exp. | $27,946 | $25,987 | $23,069 | $20,384 |
| Other Operating Expenses | $0 | $2,706 | $2,579 | $2,676 |
| Operating Expenses | $62,641 | $57,792 | $52,200 | $44,380 |
| Operating Income | -$1,932 | -$11,640 | -$201 | -$501 |
| % Margin | -2.4% | -21.5% | -0.3% | -1% |
| Other Income/Exp. Net | -$18,115 | -$6,439 | -$3,733 | -$4,906 |
| Pre-Tax Income | -$20,047 | -$18,079 | -$3,934 | -$5,407 |
| Tax Expense | $85 | $28 | $438 | -$68 |
| Net Income | -$20,132 | -$18,107 | -$4,372 | -$5,339 |
| % Margin | -24.9% | -33.5% | -7.4% | -10.5% |
| EPS | -0.79 | -2.59 | -0.66 | -1.04 |
| % Growth | 69.5% | -292.4% | 36.5% | – |
| EPS Diluted | -0.79 | -2.59 | -0.66 | -1.04 |
| Weighted Avg Shares Out | 25,562 | 6,997 | 6,595 | 5,118 |
| Weighted Avg Shares Out Dil | 25,562 | 6,997 | 6,595 | 5,118 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $10,185 | $5,881 | $5,413 | $5,380 |
| Depreciation & Amortization | $8,747 | $2,706 | $2,579 | $2,676 |
| EBITDA | -$1,115 | -$9,492 | $4,058 | $2,649 |
| % Margin | -1.4% | -17.5% | 6.9% | 5.2% |